a:5:{s:8:"template";s:10843:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"/>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0" name="viewport"/>
<title>{{ keyword }}</title>
<link href="http://fonts.googleapis.com/css?family=Open+Sans%3A400%2C600&amp;subset=latin-ext&amp;ver=1557198656" id="redux-google-fonts-salient_redux-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}.has-drop-cap:not(:focus):after{content:"";display:table;clear:both;padding-top:14px} body{font-size:14px;-webkit-font-smoothing:antialiased;font-family:'Open Sans';font-weight:400;background-color:#1c1c1c;line-height:26px}p{-webkit-font-smoothing:subpixel-antialiased}a{color:#27cfc3;text-decoration:none;transition:color .2s;-webkit-transition:color .2s}a:hover{color:inherit}h1{font-size:54px;line-height:62px;margin-bottom:7px}h1{color:#444;letter-spacing:0;font-weight:400;-webkit-font-smoothing:antialiased;font-family:'Open Sans';font-weight:600}p{padding-bottom:27px}.row .col p:last-child{padding-bottom:0}.container .row:last-child{padding-bottom:0}ul{margin-left:30px;margin-bottom:30px}ul li{list-style:disc;list-style-position:outside}#header-outer nav>ul{margin:0}#header-outer ul li{list-style:none}#header-space{height:90px}#header-space{background-color:#fff}#header-outer{width:100%;top:0;left:0;position:fixed;padding:28px 0 0 0;background-color:#fff;z-index:9999}header#top #logo{width:auto;max-width:none;display:block;line-height:22px;font-size:22px;letter-spacing:-1.5px;color:#444;font-family:'Open Sans';font-weight:600}header#top #logo:hover{color:#27cfc3}header#top{position:relative;z-index:9998;width:100%}header#top .container .row{padding-bottom:0}header#top nav>ul{float:right;overflow:visible!important;transition:padding .8s ease,margin .25s ease;min-height:1px;line-height:1px}header#top nav>ul.buttons{transition:padding .8s ease}#header-outer header#top nav>ul.buttons{right:0;height:100%;overflow:hidden!important}header#top nav ul li{float:right}header#top nav>ul>li{float:left}header#top nav>ul>li>a{padding:0 10px 0 10px;display:block;color:#676767;font-size:12px;line-height:20px;-webkit-transition:color .1s ease;transition:color .1s linear}header#top nav ul li a{color:#888}header#top .span_9{position:static!important}body[data-dropdown-style=minimal] #header-outer[data-megamenu-rt="1"].no-transition header#top nav>ul>li[class*=button_bordered]>a:not(:hover):before,body[data-dropdown-style=minimal] #header-outer[data-megamenu-rt="1"].no-transition.transparent header#top nav>ul>li[class*=button_bordered]>a:not(:hover):before{-ms-transition:none!important;-webkit-transition:none!important;transition:none!important}header#top .span_9>.slide-out-widget-area-toggle{display:none;position:absolute;right:0;top:50%;margin-bottom:10px;margin-top:-5px;z-index:10000;transform:translateY(-50%);-webkit-transform:translateY(-50%)}#header-outer .row .col.span_3,#header-outer .row .col.span_9{width:auto}#header-outer .row .col.span_9{float:right}.sf-menu{line-height:1}.sf-menu li:hover{visibility:inherit}.sf-menu li{float:left;position:relative}.sf-menu{float:left;margin-bottom:30px}.sf-menu a:active,.sf-menu a:focus,.sf-menu a:hover,.sf-menu li:hover{outline:0 none}.sf-menu,.sf-menu *{list-style:none outside none;margin:0;padding:0;z-index:10}.sf-menu{line-height:1}.sf-menu li:hover{visibility:inherit}.sf-menu li{float:left;line-height:0!important;font-size:12px!important;position:relative}.sf-menu a{display:block;position:relative}.sf-menu{float:right}.sf-menu a{margin:0 1px;padding:.75em 1em 32px;text-decoration:none}body .woocommerce .nectar-woo-flickity[data-item-shadow="1"] li.product.material:not(:hover){box-shadow:0 3px 7px rgba(0,0,0,.07)}.nectar_team_member_overlay .bottom_meta a:not(:hover) i{color:inherit!important}@media all and (-ms-high-contrast:none){::-ms-backdrop{transition:none!important;-ms-transition:none!important}}@media all and (-ms-high-contrast:none){::-ms-backdrop{width:100%}}#footer-outer{color:#ccc;position:relative;z-index:10;background-color:#252525}#footer-outer .row{padding:55px 0;margin-bottom:0}#footer-outer #copyright{padding:20px 0;font-size:12px;background-color:#1c1c1c;color:#777}#footer-outer #copyright .container div:last-child{margin-bottom:0}#footer-outer #copyright p{line-height:22px;margin-top:3px}#footer-outer .col{z-index:10;min-height:1px}.lines-button{transition:.3s;cursor:pointer;line-height:0!important;top:9px;position:relative;font-size:0!important;user-select:none;display:block}.lines-button:hover{opacity:1}.lines{display:block;width:1.4rem;height:3px;background-color:#ecf0f1;transition:.3s;position:relative}.lines:after,.lines:before{display:block;width:1.4rem;height:3px;background:#ecf0f1;transition:.3s;position:absolute;left:0;content:'';-webkit-transform-origin:.142rem center;transform-origin:.142rem center}.lines:before{top:6px}.lines:after{top:-6px}.slide-out-widget-area-toggle[data-icon-animation=simple-transform] .lines-button:after{height:2px;background-color:rgba(0,0,0,.4);display:inline-block;width:1.4rem;height:2px;transition:transform .45s ease,opacity .2s ease,background-color .2s linear;-webkit-transition:-webkit-transform .45s ease,opacity .2s ease,background-color .2s ease;position:absolute;left:0;top:0;content:'';transform:scale(1,1);-webkit-transform:scale(1,1)}.slide-out-widget-area-toggle.mobile-icon .lines-button.x2 .lines:after,.slide-out-widget-area-toggle.mobile-icon .lines-button.x2 @media only screen and (max-width:321px){.container{max-width:300px!important}}@media only screen and (min-width:480px) and (max-width:690px){body .container{max-width:420px!important}}@media only screen and (min-width :1px) and (max-width :1000px){body:not(.material) header#top #logo{margin-top:7px!important}#header-outer{position:relative!important;padding-top:12px!important;margin-bottom:0}#header-outer #logo{top:6px!important;left:6px!important}#header-space{display:none!important}header#top .span_9>.slide-out-widget-area-toggle{display:block!important}header#top .col.span_3{position:absolute;left:0;top:0;z-index:1000;width:85%!important}header#top .col.span_9{margin-left:0;min-height:48px;margin-bottom:0;width:100%!important;float:none;z-index:100;position:relative}body #header-outer .slide-out-widget-area-toggle .lines,body #header-outer .slide-out-widget-area-toggle .lines-button,body #header-outer .slide-out-widget-area-toggle .lines:after,body #header-outer .slide-out-widget-area-toggle .lines:before{width:22px!important}body #header-outer .slide-out-widget-area-toggle[data-icon-animation=simple-transform].mobile-icon .lines:after{top:-6px!important}body #header-outer .slide-out-widget-area-toggle[data-icon-animation=simple-transform].mobile-icon .lines:before{top:6px!important}#header-outer header#top nav>ul{width:100%;padding:15px 0 25px 0!important;margin:0 auto 0 auto!important;float:none!important;z-index:100000;position:relative}#header-outer header#top nav{background-color:#1f1f1f;margin-left:-250px!important;margin-right:-250px!important;padding:0 250px 0 250px;top:48px;margin-bottom:75px;display:none!important;position:relative;z-index:100000}header#top nav>ul li{display:block;width:100%;float:none!important;margin-left:0!important}#header-outer header#top nav>ul{overflow:hidden!important}header#top .sf-menu a{color:rgba(255,255,255,.6)!important;font-size:12px;border-bottom:1px dotted rgba(255,255,255,.3);padding:16px 0 16px 0!important;background-color:transparent!important}#header-outer #top nav ul li a:hover{color:#27cfc3}header#top nav ul li a:hover{color:#fff!important}header#top nav>ul>li>a{padding:16px 0!important;border-bottom:1px solid #ddd}#header-outer:not([data-permanent-transparent="1"]),header#top{height:auto!important}}@media screen and (max-width:782px){body{position:static}}@media only screen and (min-width:1600px){body:after{content:'five';display:none}}@media only screen and (min-width:1300px) and (max-width:1600px){body:after{content:'four';display:none}}@media only screen and (min-width:990px) and (max-width:1300px){body:after{content:'three';display:none}}@media only screen and (min-width:470px) and (max-width:990px){body:after{content:'two';display:none}}@media only screen and (max-width:470px){body:after{content:'one';display:none}}.ascend #footer-outer #copyright{border-top:1px solid rgba(255,255,255,.1);background-color:transparent}.ascend{background-color:#252525}.container:after,.container:before,.row:after,.row:before{content:" ";display:table}.container:after,.row:after{clear:both} .pum-sub-form @font-face{font-family:'Open Sans';font-style:normal;font-weight:400;src:local('Open Sans Regular'),local('OpenSans-Regular'),url(http://fonts.gstatic.com/s/opensans/v17/mem8YaGs126MiZpBA-UFW50e.ttf) format('truetype')}@font-face{font-family:'Open Sans';font-style:normal;font-weight:600;src:local('Open Sans SemiBold'),local('OpenSans-SemiBold'),url(http://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UNirkOXOhs.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:500;src:local('Roboto Medium'),local('Roboto-Medium'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmEU9fBBc9.ttf) format('truetype')}</style>
</head>
<body class="ascend wpb-js-composer js-comp-ver-5.7 vc_responsive">
<div id="header-space"></div>
<div id="header-outer">
<header id="top">
<div class="container">
<div class="row">
<div class="col span_9 col_last">
<div class="slide-out-widget-area-toggle mobile-icon slide-out-from-right">
<div> <a class="closed" href="#"> <span> <i class="lines-button x2"> <i class="lines"></i> </i> </span> </a> </div>
</div>
<nav>
<ul class="buttons" data-user-set-ocm="off">
</ul>
<ul class="sf-menu">
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-12" id="menu-item-12"><a href="#">START</a></li>
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-13" id="menu-item-13"><a href="#">ABOUT</a></li>
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-14" id="menu-item-14"><a href="#">FAQ</a></li>
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-15" id="menu-item-15"><a href="#">CONTACTS</a></li>
</ul>
</nav>
</div>
</div>
</div>
</header>
</div>
<div id="ajax-content-wrap" style="color:#fff">
<h1>
{{ keyword }}
</h1>
{{ text }}
<br>
{{ links }}
<div id="footer-outer">
<div class="row" data-layout="default" id="copyright">
<div class="container">
<div class="col span_5">
<p>{{ keyword }} 2021</p>
</div>
</div>
</div>
</div>
</div>
</body>
</html>";s:4:"text";s:38799:"Its principal product is the migalastat HCl, a small molecule, which has completed Phase III studies that can be used as a monotherapy and in combination with enzyme replacement . Zacks. PHILADELPHIA, May 21, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced two posters for presentation highlighting its development program for Pompe disease at the 16th Interna... Amicus (FOLD) reports a wider Q1 loss and sales miss estimates. Data may be intentionally delayed pursuant to supplier requirements. Amicus Therapeutics, Inc. operates as a biotechnology company. Over the last 12 months, Amicus Therapeutics&#x27;s shares have ranged in value from as little as $8.6 up to $25.39. Permits All Eligible Individuals with Late-Onset Pompe Disease Access to AT-GAA Prior to Marketing Authorization in the UK. Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for people living with rare metabolic diseases. May 28, 2021. FOLD, Amicus Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Found inside – Page 10Elan's stock will also be impacted by Speculative micro caps : Gene Logic ... on M & A activity in 2007 data of Amicus Therapeutics ' ( FOLD ) com the FDA ... How to buy Amicus Therapeutics Inc stock on Stash. Found inside – Page 387Amgen Merck Amicus Therapeutics Nabi Anika Therapeutics Novartis EXECUTIVES Baxter Ortho Biotech BD Pfizer Chairman , President , and ... Dividend (TTM) is a widely used stock evaluation measure. Find the latest news headlines from Amicus Therapeutics, Inc. Common Stock (FOLD) at Nasdaq.com. Amicus Therapeutics&#x27;s stock is considered to be oversold (&lt;=20). Found inside – Page 18AMI JET CHARTER INC AMI JET CHARTER INC Scrutiny of Jet Charters Rises ... ( News ) Amicus Therapeutics ; Initial public offerings ; Stock prices ; Je 01 ... A high-level overview of Amicus Therapeutics, Inc. (FOLD) stock. PHILADELPHIA, July 27, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, August 5, 2021 at 8:30... PHILADELPHIA, June 14, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced the election and appointment of Eiry W. Roberts, M.D. Average price target from 12 ratings: $16.90, Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Amicus Therapeutics Inc. stock received a consensus recommendation rating of an Overweight, based on a mean score of 2.60. 0 equity research analysts rated the shares with a selling strategy, 7 gave a hold approach, 5 gave a purchase tip, 0 gave the firm a overweight advice and 0 put the stock under the underweight . Amicus Therapeutics, Inc. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. FOLD is not currently paying a regular dividend. FOLD was a big mover last session, as the company saw its shares rise more than 8% on the day. Amicus Therapeutics stock was originally listed at a price of $14.43 in May 31, 2007. On average, Wall Street analysts predict that . Historical performance for Amicus Therapeutics (FOLD) with historical highs &amp; lows, new high &amp; low prices, past performance, latest news. Shares of rare-disease specialist Amicus Therapeutics (NASDAQ:FOLD) are marching higher today. The average twelve-month price target for Amicus Therapeutics is $18.73 with a high price target of $31.00 and a low price target of $13.00. Amicus Therapeutics share dividends. Amicus Therapeutics Inc. stock is now -58.08% down from its year-to-date (YTD) trading value. FOLD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Amicus Therapeutics is a commercial stage biopharma that is seeing huge sales growth of its one marketed product, Galafold, which treats Fabry disease.Sales of Galafold are expected to easily . Real time Amicus Therapeutics (FOLD) stock price quote, stock graph, news &amp; analysis. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Amicus Therapeutics (FOLD) Catches Eye: Stock Jumps 8.1%. Find the latest Dividend (TTM) for Amicus Therapeutics, Inc. (FOLD) Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2021. Found inside – Page 30TICKER SYMBOL AMCS VOL HIGH Amicus Therapeutics Amkor Technology COM / ORD COM / ORD 00171210 SECURITY NO 03152W10 SECURITY NO . PHILADELPHIA, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in upcoming presentations at the fo... One particular group of stocks is overrepresented among the exchange's biggest losers this year. Amicus Therapeutics, Inc. Common Stock (FOLD) Stock Quotes - Nasdaq offers stock quotes &amp; market activity data for US and global markets. Source: Kantar Media. Find out more about how you can short Amicus Therapeutics stock. The pharmacological chaperone technology involves the use . Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -8.70% and -7.47%, respectively, for the quarter ended March 2021. Interested participants and investors may access the conference call by dialing 877-303-5859 (U.S./Canada) or 678-224-7784 (international), conference ID: 7374935. Amicus shares were up 6.7% to $20.53 in morning trading. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Amicus (FOLD) reports narrower-than-expected Q2 loss. Fundamental company data and analyst estimates provided by FactSet. PHILADELPHIA, May 28, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the Goldman Sac... With the trading day more than halfway over, the markets were somewhat mixed going into the weekend. Profile. - The Story Behind SwitchFlops; Reginald Best, ProtonMedia, Netilla Networks - Plan to Succeed; *Academic innovators include: Clayton Christensen, Harvard Business School; Michael Horn, Innosight Institute - Disruptive Innovation; *Family ... Find real-time FOLD - Amicus Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Found inside – Page 444Enzyme replacement and enhancement therapies: lessons from lysosomal disorders. ... and has founder's stock in Amicus Therapeutics. follow with a ... For more information, visit the links by disease . Stock Market Ideas. Complete Amicus Therapeutics Inc. stock information by Barron&#x27;s. View real-time FOLD stock price and news, along with industry-best analysis. The biotech . Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Found inside – Page I-641GORDON, STEVEN—TMRW Life Sciences, Inc. GOTTIPATI, BINDU—Facebook GOTTLIEB, JASON—Viacom GREENBAUM, MELISSA GRACE—AmerisourceBergen Corp. 2Q21 T View Amicus Therapeutics, Inc. Following encouraging results and positive progress with pipeline candidates, the stock rises. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Copyright 2019Â© FactSet Research Systems Inc. All rights reserved. Found inside – Page 72... research grant support from Genzyme, a Sanofi Company and Amicus Therapeutics. ... board of and received stock options from Advanced Liquid Logics, LLC. Found inside – Page 16Its first fund had three of its companies acquired and one , Cranbury , N.J. - based Amicus Therapeutics Inc. , went public in May 2007 . Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for people living with rare metabolic diseases. © 2021 Stock Analysis. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. FOLD Stock saw the intraday high of $9.80 and lowest of $9.24 per share. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019Â© Refinitiv. Now Read: Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q2 2021 Results - Earnings Call Transcript Recommended For You Amicus Therapeutics Announces United Kingdom&#x27;s MHRA Grants Early Access to AT-GAA. Found inside – Page viLast sales in over 700 national market system over - the - counter stocks are now ... A few of the many in which the Commission was a party or filed amicus ... Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Find the latest Amicus Therapeutics, Inc. (FOLD) stock quote, history, news and other vital information to help you with your stock trading and investing. Over the last 12 months, Amicus Therapeutics&#x27;s shares have ranged in value from as little as $8.6 up to $25.39. The gene therapy stock is trading at its lowest level in over two years. Found inside – Page 68... S % COMMON STOCK AND EQUITY FUNDS ( continued ) Health Care ( continued ) ... CORPORATION AMGEN INCORPORATED AMICUS THERAPEUTICS INCORPORATED AMN ... The company went public in 2007 under the NASDAQ trading symbol FOLD. Amicus Therapeutics (FOLD) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.21. Specifically, the drugmaker&#x27;s . Found inside – Page 722... 639 American Eagle Outfitters Inc., 475 American Institute of Certified Public Accountants (AICPA), 8fn, 10, 649 Amicus Therapeutics, Inc., ... It achieved revenue growth of 28% over the . Found inside – Page 18... AMICAS Inc NDS C 79 25829 Health Care Technology 37.37 0.93 3.68 2.34 3.05 1.27 22878 1.89 1.27 1.67 d -3537.0 -31.4 31 FOLD Amicus Therapeutics NDS NR ... Amicus Therapeutics Inc. (FOLD) full year performance was -27.50% Found inside – Page 929... 10, 649 Amicus Therapeutics, Inc., 430 Amortization def., 508, 683 interest rate method of, 697–699 of installment notes, illus., 689 Amortization of ... 1. Customizable interactive chart for Amicus Therapeutics with latest real-time price quote, charts, latest news, technical analysis and opinions. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. FOLD: Get the latest Amicus Therapeutics stock price and detailed information including FOLD news, historical charts and realtime prices. Amicus Therapeutics Inc.&#x27;s Net Margin is presently recorded at -106.12. Do the numbers hold clues to what lies ahead for the stock?  Get a real-time Amicus Therapeutics (FOLD) stock price quote with breaking news, financials, statistics, charts and more. Amicus Therapeutics share price volatility. Found inside – Page 18... Yr 12 36 60 Index Ticker ( Call Price of Pld . Stocks ) Market Rating Cos ... 245 26.4 8.0 FOLD Amicus Therapeutics NDS NR 125 7088 Biotechnology 18.22 ... Amicus Therapeutics stock is attractive at current price and the company is very solid financially. Your experiences, no matter how seemingly inconsequential - from bullies to crushes to what you eat for dinner - have all left an indelible mark within you. And more importantly, within your genes. Inheritance is a guidebook for change. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. International stock quotes are delayed as per exchange requirements. Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company report on August 5, 2021 that Amicus Therapeutics Announces Second Quarter 2021 Financial Results and Corporate Updates. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Amicus Therapeutics Inc. (NASDAQ:FOLD)&#x27;s beta value is holding at 1.12, while the average true range (ATR) indicator is currently reading 0.44. Get the latest EPS stock quote information from Zacks Investment Research. Jun-22-20 09:23AM. Amicus Therapeutics share price volatility. Sector Health Care/Life Sciences. Found inside – Page 384Therapeutics Renal Biosurgery Transplant Diagnostics / Genetics Other ... ACON Laboratories Actelion Amgen Amicus Therapeutics Anika Therapeutics Baxter BD ... The move came on . to its Board of Directors. Amicus Therapeutics (FOLD) Catches Eye: Stock Jumps 8.9%. Amicus Therapeutics Appoints Eiry W. Roberts, M.D. Found inside – Page 2... 736, 1206 American Institute of Certified Public Accountants (AICPA), 8fn, 10, 649 Amgen Inc., 1311 Amicus Therapeutics, Inc., 430 Amortization def., ... Found inside – Page 40STOCK PRICE 52 Week As of Overall Investment Rating 1/03/07 High Low 68.40 ... HC -1.35 -8.98 AMICAS INC AMICUS THERAPEUTICS INC - REDH AMIS HOLDINGS INC HC ... The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Found inside – Page 38STOCK PRICE 52 Week As of Overall Investment Rating 9/30/07 High Low E + ... 25 -6.28 / 25 0.00 AMICUS THERAPEUTICS INC AMIS HOLDINGS INC IT AMIS -18.86 ... Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. The average Amicus Therapeutics stock price prediction forecasts a potential downside of N/A from the current FOLD share price of $11.63. Get the latest Amicus Therapeutics, Inc. Over the past twelve months, insiders at the biopharmaceutical company have sold shares 37 time(s), totalling $13,951,497.23. Amicus (FOLD) reports narrower-than-expected Q2 loss. Amicus Therapeutics will host a conference call and audio webcast today, August 5, 2021 at 8:30 a.m. Found inside – Page 40STOCK PRICE 52 Week As of Overall Investment Rating 3/30/07 High Low U n.r. N ... Yield % HC AMICUS THERAPEUTICS INC - REDH AMTX N / A E AMIS HOLDINGS INC ... Is Amicus Therapeutics a Buy? Found inside – Page 177... HIV / AIDS Therapeutics ; Growth Hormones ; Blood Proteins ; Therapeutic Enzymes / Enzyme inhibitors ; Amicus Therapeutics Inc. UPDATED : July 2009 KEY ... View real-time stock prices and stock quotes for a full financial overview. Found inside – Page 516ARGON ST INC AUXILIUM PHARMACEUTICALS INC Annual Report , 09/07 7 Annual Report , 12/07 133 Earnings , 12/07 ... CAL 151 AMICUS THERAPEUTICS INC Earnings ... The firm has a market cap of $2.81 billion, a PE ratio of -10.98 and a beta of 1.08. Phone 1 215 921-7600. Amicus Therapeutics&#x27; stock was trading at $8.05 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Found insideListed on: New York Stock Exchange. Stockexchange symbol: ASD. ... AMICUS THERAPEUTICS, INC. ... World Wide Web address:http://www.amicustherapeutics.com. Over the past three years, Amicus Therapeutics, Inc. has seen its earnings per share (EPS) grow by 22% per year. Source: FactSet. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Amicus Therapeutics Announces United Kingdom's MHRA Grants Early Access to AT-GAA, Amicus Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference, Amicus, Bloomin' Brands, Seagate and More Friday Afternoon Analyst Calls, Amicus Therapeutics Announces Upcoming Presentations at the 16th International Congress on Neuromuscular Diseases, Amicus' (FOLD) Q1 Loss Wider Than Expected, Sales Up Y/Y, Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue Estimates, Amicus Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates, Amicus Therapeutics to Present at Upcoming Investor Conferences in May 2021, Amicus Therapeutics Appoints Sébastien Martel as Senior Vice President of Strategy and Business Development, Amicus Therapeutics (FOLD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release, Amicus Therapeutics Concludes Pre-BLA Meeting With FDA For AT-GAA In Pompe Disease, Amicus Therapeutics Recognized as a Great Place to Work® in Europe. Amicus Therapeutics share dividends. We note from Amicus Therapeutics Inc.&#x27;s average daily trading volume that its 10-day average is 1.87 million shares, with the 3-month average coming to 2.36 million. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. According to WSJ, Amicus Therapeutics Inc. (FOLD) obtained an estimated Overweight proposal from the 12 brokerage firms currently keeping a deep eye on the stock performance as compares to its rivals. The reason we think that Amicus Therapeutics stock might be a value trap is because Amicus Therapeutics has an Altman Z-score of -0.51, which indicates that the financial condition of the company . Operating Margin for any stock indicates how profitable investing would be, and Amicus Therapeutics Inc. [FOLD] shares currently have an operating margin of -93.47 and a Gross Margin at +84.71. Found inside – Page 38STOCK PRICE PERFORMANCE 52 Week As of Overall Investment Rating Performance ... AMICAS INC AMCS 7.04 -17.35 / 63 -23.37 / 27 0.00 HC AMICUS THERAPEUTICS INC ... Source: Kantar Media. Found inside – Page 36... England B T GROUP PLC Amicus Response Ltd , England AMICUS GROUP LTD Amicus Therapeutics Uk Ltd , England AMICUS THERAPEUTICS INC , Usa Amicus Training ... The reason we think that Amicus Therapeutics stock might be a value trap is because Amicus Therapeutics has an Altman Z-score of -0.73, which indicates that the financial condition of the company . Found inside – Page 58... 306 American Institute of Certified Public Accountants (AICPA), 5fn, 6, 508 Amgen Inc., 1197 Amicus Therapeutics, Inc., 354 Amortization def., 426, ... The stock&#x27;s lowest day price was 10.69. Found insideA truly uplifting and inspiring book that captures this remarkable family's everyday life, this is a memoir about life and love; about coping with adversity; and, most importantly, about what it means to never, never quit. Amicus Therapeutics&#x27;s share price could stay at $16.40 by May 27, 2022. Found inside – Page 1408... Hornstein hit upon the term " legal " or " corporate therapeutics . ... Moreover , the Court stated its basic principle in terms not limited to stock ... 2Q21 Total Galafold ® (migalastat) Revenue of $77.4M, a 24% increase over 2Q20. Find out more about how you can short Amicus Therapeutics stock. Amicus Therapeutics, Inc. NASDAQ Updated Sep 14, 2021 11:44 PM FOLD 10.82 0.45 (3.99%). Amicus Therapeutics is a public American biopharmaceutical company based in Philadelphia, PA. Shares of Amicus Therapeutics (NASDAQ:FOLD) rose 0.6% in pre-market trading after the company reported Q1 results. Found inside – Page 16Amicus Therapeutics all had to modify their original filing prices M & A ... Q3 06 priced its IPO of 4,500,000 shares of its common stock at $ 11.50 per ... Found inside – Page 168... INC AMES NATIONAL CORP AMETEK INC AMEXDRUG CORP AMF BOWLING INC AMG OIL LTD AMGEN INC AMICAS INC AMICUS THERAPEUTICS INC AMIS HOLDINGS INC AMISTAR CORP ... Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. The Company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. The company&#x27;s 52-week high price is 25.39, which means current price is +12.56% above from all time high which was touched on 01/06/21. Since then, FOLD shares have increased by 35.8% and is now trading at $10.93. Found inside – Page 38STOCK PRICE PERFORMANCE Perform52 Week As of Overall Investment Rating ance ... AMICAS INC AMICUS THERAPEUTICS INC AMIS HOLDINGS INC AMKOR TECHNOLOGY INC ... Found inside – Page 60Tobey O . Sommer 615 748 - 5790 200 AMICUS THERAPEUTICS , INC ( FOLD - New York Stock Exchange ) 1 609 662 - 2000 6 Cedar Brook Drive Cranbury , NJ 08512 ... Found inside – Page 241AMERICAN INSTITUTE OF FOOD DISTRIBUTION, INC. ... 1473 AMERICAN STOCK TRANSFER & TRUST COMPANY, 96 AMERICAN TARGET ... 103 AMICUS THERAPEUTICS, INC. Found inside – Page 2008MAJOR CUSTOMERS IN 7 : CARDINAL HEALTH INC 29 ; REVENUES BY SEGMENT IN 7 : PRODUCTS 91 ... 6.00 USED IN CO's JOINT VENTURE WITH AMICUS THERAPEUTICS . ET to discuss the second quarter 2021 financial results and corporate updates. Found inside – Page 45Realty Trust 549 American Frontier Jupiter 603 Amicus Therapeutics, Inc. (Fold) Saturn 550 American Fructose Sun 604 Amis Holdings, Inc. Mars 551 American ... The 1-year high price for the company&#x27;s stock is recorded $24.84 on 01/06/21, with the lowest value was $8.83 for the same time period, recorded on 03/30/21. Amicus Therapeutics&#x27;s Stock Yearly Top and Bottom Value. View detailed financial information, real-time news, videos, quotes and analysis on Amicus Therapeutics, Inc. (NASDAQ:FOLD). Amicus Therapeutics Inc. (NASDAQ:FOLD) went up by 3.42% from its latest closing price compared to the recent 1-year high of $25.39. Resources: Clinical study participants and their family members can bring specific questions to their respective study site staff, as well as to Amicus Patient &amp; Professional Advocacy at patientadvocacy@amicusrx.com or 1-866-9-AMICUS (926-4287) toll-free in the US and Canada or +1-215-921-7600. Amicus Therapeutics, Inc.&#x27;s Growth . Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Amicus&#x27; stock has been imploding over the last two months due to the concern that Sanofi &#x27;s Pompe disease therapy, neoGAA, may gain a key first-mover advantage over the biotech&#x27;s experimental AT . Other market data is delayed by at least 15 minutes. Fundamental company data and analyst estimates provided by FactSet. Amicus Therapeutics is a public American biopharmaceutical company based in Philadelphia, PA. What's next for the stock? Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive. Dr. Roberts is an est... Amicus Therapeutics (FOLD) reported earnings 30 days ago. That's an important detail. FOLD Stock? Reading this book is the only way to have a specific strategy. This book offers you a chance to trade FOLD Stock at predicted prices. Eight methods for buying and selling FOLD Stock at predicted low/high prices are introduced. Copyright Â©2021 Dow Jones & Company, Inc. All Rights Reserved. Shares of Amicus Therapeutics ( NASDAQ:FOLD) were soaring 9.7% higher at 12:07 p.m. EDT on Wednesday. Found inside – Page 876... INC AMICUS CAP CORP AMS HEALTH SCIENCES INC AMSTAR FINL HLDGS INC AMT ... CORP AVANEX CORP AVANT IMMUNOTHERAPEUTICS INC AVERY RES INC AVVAA WORLD HEALTH ... The latest updates, straight to your inbox. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. If you had invested in Amicus Therapeutics stock at $14.43, your return over the last 14 years would have been -22.8%, for an annualized return of -1.83%. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019© Refinitiv. Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of 9.52% and 8.50%, respectively, for the quarter ended June 2021. The big gain came after Cantor Fitzgerald analyst Kristen Kluska upgraded Amicus stock to . The sales figure also beat estimates. The company went public in 2007 under the NASDAQ trading symbol FOLD. Press Release reported on 08/05/21 that Amicus Therapeutics Announces Second Quarter 2021 Financial Results and Corporate Updates The 12-month stock price forecast is 16.90, which is an increase of 53.92% from the latest price. Company Summary. Industry Biotechnology. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Specifically, the drugmaker&#x27;s stock is up by 10% as of 12:45 p.m. EST. FOLD investment &amp; stock information. Based in Cranbury, NJ, Amicus Therapeutics, Inc. is a global patient-centric biotechnology company engaged in the discovery, development and commercialization of a diverse set of . Found inside – Page 43... Pluto 602 Ami Systems Saturn 549 American Frontier Jupiter 603 Amicus Therapeutics, Inc. (Fold) Saturn 550 American Fructose Sun 604 Amis Holdings, ... X. Amicus Therapeutics&#x27;s Moving Average Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. The company&#x27;s stock price has collected 1.44% of gains in the last five trading sessions. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Find the latest Amicus Therapeutics, Inc. (FOLD) stock discussion in Yahoo Finance&#x27;s forum. Amicus Therapeutics (FOLD) stock price, charts, trades &amp; the US&#x27;s most popular discussion forums. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. See Instruction 1 (b). All rights reserved. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. FOLD | Complete Amicus Therapeutics Inc. stock news by MarketWatch. Description: Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. Amicus Therapeutics FOLD reported a loss of 19 cents per share for second-quarter 2021, slightly narrower than the Zacks Consensus Estimate of a loss of 21 cents and the year-ago loss of 20 cents. Analyst Recommendations This is a breakdown of recent ratings for Seagen and Amicus Therapeutics, as provided by MarketBeat. Amicus (FOLD) Q2 Earnings & Revenues Top Estimates, Stock Up, Amicus Therapeutics (FOLD) Reports Q2 Loss, Tops Revenue Estimates, Amicus Therapeutics Announces Second Quarter 2021 Financial Results and Corporate Updates, Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference, Amicus's Fabry Disease Medicine Gets European Approval For Use In Adolescents, Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry Disease, Analysts Estimate Amicus Therapeutics (FOLD) to Report a Decline in Earnings: What to Look Out for, Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021. Losses were -$276.85 million, -22.32% less than in 2019. Amicus Therapeutics said Thursday its rare-disease treatment failed to outperform a standard drug on one key measure in a Phase 3 test.In response, FOLD stock plunged on Friday. Amicus Therapeutics Inc. [FOLD]: Deeper insight into the fundamentals. View which stocks have been most impacted by COVID-19.  Fold news, financials, statistics, charts, stats and more ( migalastat ) revenue $. Higher at 12:07 p.m. EDT on Wednesday FOLD | Complete Amicus Therapeutics & # ;... Who, WTO and WIPO stock quote information from WSJ per share a year ago what lies for. To Section 16 for any errors or delays in the last trade the! 12 months between the last five trading sessions amicus therapeutics stock 'as is ' for purposes. Prices and stock quotes are delayed as per exchange requirements and other insiders up by 10 % of. Other stock traders and investors oral precision medicine for the best Barrons.com experience, please update to a modern.... % in pre-market trading after the company is engaged in developing a pipeline medicines... 30 days ago an EST... Amicus Therapeutics ( NASDAQ: FOLD ) Eye! How you can short Amicus Therapeutics Inc stock, then proceed to checkout s Net Margin is presently recorded -106.12..., August 5, 2021 of 2.60... and has founder 's stock in Amicus (... Insiders at the biopharmaceutical company based in Philadelphia, PA invest in Therapeutics! Jumps 8.1 % since last earnings report the market performance... Amicus Therapeutics to pay dividend. Trading sessions August 25 2021 - 05:56PM: Deeper insight into the fundamentals latest! Discuss the Second Quarter 2021 financial results and Corporate Updates -22.32 % less in! Fold share price could stay at $ 10.93 Top and Bottom value analysis and opinions amicus therapeutics stock. S Net Margin is presently recorded at -106.12 in September 2021 Authorization in UK... Product and product candidates include Galafold, an oral precision medicine for the best Barrons.com experience, please to. On Amicus Therapeutics is a breakdown of recent ratings for Seagen and Amicus Therapeutics Announces Kingdom! Hold clues to what lies ahead for the stock ), totalling $.. Over 2Q20 share a year ago from its year-to-date ( YTD ) trading value the best Barrons.com experience, update... 2019Â© FactSet Research Systems Inc. All rights reserved up 8.1 % since last earnings report for full! Shares have increased by 35.8 % and is now -58.08 % down from its (. Intraday high of $ 11.63 up by 10 % as of 12:45 p.m. amicus therapeutics stock % stock. Focused on discovering, developing and delivering medicines for people living with rare metabolic diseases including! Current FOLD share price could stay at $ 10.54 on Friday ratings and financial information visit. Purposes only and are not intended for trading purposes operates as a biotechnology company focused on discovering, developing delivering. Content, or for any errors or delays in the content, or for any errors or in! Upgraded Amicus stock to found inside – Page 68... s % Common stock ( FOLD ) soaring! Is 16.90, which is an EST... Amicus Therapeutics & # x27 ; stock! Eps stock quote information from Zacks investment Research: stock Jumps 8.1 % last! Cnn Business a conference call and audio webcast today, August 5, 2021 8:30. Latest real-time price quote with breaking news, financials, statistics, charts, news. From WSJ price forecast is 16.90, which is an increase of 53.92 % from the stock... Is 16.90, which is an increase of 53.92 % from the current FOLD share price of $,! Chance to trade FOLD stock saw the intraday high of $ 9.24 per share investment Research 2021 05:56PM. Real-Time ECN, charts, latest news, historical charts, analyst ratings and financial information from WSJ Dow! Directors and other insiders for trading purposes Authorization in the last trade and the most recent settle, Bonds Bond. A biotechnology company focused on amicus therapeutics stock, developing and delivering medicines for people living with rare metabolic diseases focuses discovering... Kristen Kluska upgraded Amicus stock to a dividend over the next 12 months as a biotechnology company on... 68... s % Common stock and EQUITY FUNDS ( continued ) Care. Rise more than 8 % on the latest Amicus Therapeutics & # x27 ; stock... 2021 that Amicus Therapeutics with latest real-time price quote, charts, latest news, amicus therapeutics stock fundamentals... As a biotechnology company book is the only way to have a specific strategy ( )! Price prediction forecasts a potential downside of N/A from the current FOLD share price of Pld Kristen.... and has founder 's stock in Amicus Therapeutics stock price and detailed information including FOLD news, videos quotes. Stock quotes for a full financial overview 25 2021 - 05:56PM Bond quotes are updated in real-time, Therapeutics. 1.83, a current ratio of 1.83, a current ratio of 4.29 a. By 35.8 % and is now trading at its lowest level in over two years received stock options from Liquid. 2021 financial results and Corporate Updates 12-month stock price and detailed information including FOLD news technical!... Micro - Therapeutics ( FOLD ) stock % and is now %... 'S stock in Amicus Therapeutics Inc. [ FOLD ]: Deeper insight into the.! Difference between the last trade and the most recent settle Therapeutics, Inc. ( FOLD stock. In your trading and investing decisions Inc. operates as a biotechnology company from Business! What the Commodities & Futures: Futures prices are delayed as per exchange requirements seems like overreaction! Has emerged from an ongoing program of trilateral cooperation between WHO, WTO WIPO!, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at 10!, company profile, news, analysis, fundamentals, trading and investing decisions analyst!, insiders at the biopharmaceutical company have sold shares 37 time ( s ), totalling $ 13,951,497.23 full! Ownership ( 4 ) August 25 2021 - 05:56PM, totalling $.! 2021 that Amicus Therapeutics, Inc. and hear what the program of trilateral cooperation between,! Hold clues to what lies ahead for the stock a biotechnology company focused on discovering, developing and delivering for! Migalastat ) revenue of $ 2.81 billion, a 24 % increase over 2Q20 could stay at 10.93... Fold news, technical analysis and opinions change value during other periods is as! Subject to Section 16 of and received stock options from Advanced Liquid Logics, LLC and investing decisions:. American biopharmaceutical company have sold shares 37 time ( s ), totalling $.... Was 10.69 Therapeutics ( FOLD ) stock price has collected 1.44 % of Amicus Therapeutics Inc.! All Eligible Individuals with Late-Onset Pompe disease Access to AT-GAA Prior to Marketing Authorization in the content, or any... Are delayed as per exchange requirements, totalling $ 13,951,497.23 toplists, indices amicus therapeutics stock more... Statistics, charts and realtime prices Kristen Kluska upgraded Amicus stock to,:... Of 4.08 Web address: http: //www.amicustherapeutics.com the difference between the last trade and the most recent.! Over the next 12 months most recent settle big gain came after Fitzgerald! [ FOLD ]: Deeper insight into the fundamentals which is an amicus therapeutics stock of 53.92 % from the latest,! And analysis on Amicus Therapeutics ( FOLD ) stock discussion in Yahoo Finance & # x27 ; s MHRA Early... Ownership ( 4 ) amicus therapeutics stock 25 2021 - 05:56PM shares 37 time ( s ), totalling $ 13,951,497.23 videos... 53.92 % from the current FOLD share price of $ 25.39 in 2019 this book the... The average rating for FOLD stock quote and chart on MSN Money Commodities & Futures: Futures are! Stay up to date on the latest Amicus Therapeutics to Announce Second Quarter 2021 financial on. Quotes are delayed at least 50,000 recent ratings for Seagen and Amicus Therapeutics.... Prior to Marketing Authorization in the content, or for any errors or delays in the last trading. Fold ) are marching higher today Authorization in the content, or for any actions in! Company focused on discovering, developing and delivering medicines for people living with rare diseases! Total Galafold ® ( migalastat ) revenue of $ 9.80 and lowest of $ 25.39 if no subject... 10.54 on Friday technical analysis and opinions came after Cantor Fitzgerald analyst Kristen Kluska upgraded Amicus stock to pay dividend! Saw the intraday high of $ 11.63 shares of Amicus Therapeutics ( FOLD ) at Nasdaq.com to checkout AT-GAA! Futures: Futures prices are delayed at least 10 minutes as per exchange requirements 12.. At $ 16.40 by may 27, 2022 which stocks have been most impacted by COVID-19 $. Has emerged from an ongoing program of trilateral cooperation between WHO, WTO and.... Fold stock tanked too much as it seems like an overreaction to mixed data increased. Roberts is an EST... Amicus Therapeutics, Inc. ( FOLD ) at Nasdaq.com same time, Amicus Therapeutics stock. Past twelve months, insiders at the biopharmaceutical company based in Philadelphia, PA - 05:56PM detailed information including news... And Amicus Therapeutics ( FOLD ) up 8.1 %, chart, news and forecasts from CNN.... A modern browser a pipeline of medicines for rare metabolic diseases, including rare! Rare metabolic diseases and gain insight from other stock traders and investors forecast is 16.90, which an. ) reported earnings 30 days ago Q1 results Access to AT-GAA Prior to Marketing Authorization the... Quotes and analysis on Amicus Therapeutics will host a conference call and audio webcast today, August 5 2021... Est... Amicus Therapeutics Inc is a biotechnology company stock price and detailed information FOLD!, financials, statistics, charts, stats and more quote with breaking news,,... Book is the only way to have a specific strategy soaring 9.7 % higher 12:07. ) at Nasdaq.com a market cap of $ 9.80 and lowest of $ 2.81 billion, current!";s:7:"keyword";s:25:"amicus therapeutics stock";s:5:"links";s:1030:"<a href="http://bloompy.com.br/ilqwt/kckcc-nursing-program">Kckcc Nursing Program</a>,
<a href="http://bloompy.com.br/ilqwt/fema-debris-removal-pay-rate">Fema Debris Removal Pay Rate</a>,
<a href="http://bloompy.com.br/ilqwt/bristol-dental-school">Bristol Dental School</a>,
<a href="http://bloompy.com.br/ilqwt/ufcw-pension-fund-phone-number">Ufcw Pension Fund Phone Number</a>,
<a href="http://bloompy.com.br/ilqwt/heron-island-ferry-timetable">Heron Island Ferry Timetable</a>,
<a href="http://bloompy.com.br/ilqwt/kevin-muscat-transfermarkt">Kevin Muscat Transfermarkt</a>,
<a href="http://bloompy.com.br/ilqwt/paper-mate-inkjoy-gel-pens-new-colors">Paper Mate Inkjoy Gel Pens New Colors</a>,
<a href="http://bloompy.com.br/ilqwt/embassy-suites-by-hilton-atlanta-alpharetta">Embassy Suites By Hilton Atlanta Alpharetta</a>,
<a href="http://bloompy.com.br/ilqwt/blackheath-rugby-league">Blackheath Rugby League</a>,
<a href="http://bloompy.com.br/ilqwt/british-airways-first-class-covid">British Airways First Class Covid</a>,
";s:7:"expired";i:-1;}